Lataa...
Prostanoid therapies in the management of pulmonary arterial hypertension
Prostacyclin is an endogenous eicosanoid produced by endothelial cells; through actions on vascular smooth-muscle cells, it promotes vasodilation. Pulmonary arterial hypertension (PAH) is characterized by elevated mean pulmonary artery pressure due to a high pulmonary vascular resistance state. A re...
Tallennettuna:
| Julkaisussa: | Ther Clin Risk Manag |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386780/ https://ncbi.nlm.nih.gov/pubmed/25848300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S75122 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|